Bioconjugate Chemistry

What biosimilar or generic tirzepatide candidates are in clinical development or awaiting approval (as of Nov 2025)?

As of the sources through 2025, there are no FDA‑approved generic or biosimilar versions of tirzepatide (sold as Mounjaro/Zepbound); multiple industry and regulatory notices say generics are not avail...